These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37192749)

  • 21. Financial impact of oral chemotherapy wastage on society and the patient.
    Monga V; Meyer C; Vakiner B; Clamon G
    J Oncol Pharm Pract; 2019 Jun; 25(4):824-830. PubMed ID: 29575989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents.
    Doshi JA; Li P; Huo H; Pettit AR; Armstrong KA
    J Clin Oncol; 2018 Feb; 36(5):476-482. PubMed ID: 29261440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recycling unused medications in hospitals is financially viable and good for the environment.
    Drummond I; Bains R; Dosanjh A; Ladhar S; Tang L; Heidary D; Tejani AM
    Int J Pharm Pract; 2023 Sep; 31(5):562-564. PubMed ID: 37566550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
    Carroll NV; Rupp MT; Holdford DA
    J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution.
    Campbell GA; Vallejo E
    J Pharm Sci; 2015 Jan; 104(1):52-62. PubMed ID: 25393927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of risks associated with the prescribing and dispensing of oral anticancer medicines in Ireland.
    Hammond L; Marsden E; O'Hanlon N; King F; Henman MC; Keane C
    Int J Clin Pharm; 2012 Dec; 34(6):893-901. PubMed ID: 22961608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding pharmacy practice through the use of pharmacy technicians as process navigators to facilitate patient access of oral anticancer agents.
    Lau G; Alwan L; Chi M; Lentz M; Hone K; Segal E
    J Am Pharm Assoc (2003); 2019; 59(4):586-592. PubMed ID: 31036528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
    JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacy benefit spending on oral chemotherapy drugs.
    Curtiss FR
    J Manag Care Pharm; 2006 Sep; 12(7):570-7. PubMed ID: 16981802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospital Audit as a Useful Tool in the Process of Introducing Falsified Medicines Directive (FMD) into Hospital Pharmacy Settings-A Pilot Study.
    Religioni U; Swieczkowski D; Gawrońska A; Kowalczuk A; Drozd M; Zerhau M; Smoliński D; Radomiński S; Cwalina N; Brindley D; Jaguszewski MJ; Merks P
    Pharmacy (Basel); 2017 Nov; 5(4):. PubMed ID: 29120385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose standardisation of anticancer drugs.
    Pouliquen AL; Escalup L; Jourdan N; Cottu P; Faure P; Madelaine-Chambrin I
    Int J Clin Pharm; 2011 Apr; 33(2):221-8. PubMed ID: 21369959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acceptance of an oncologic addendum for the application of the German Standardized Medication Plan in oral anticancer drug therapy].
    Barnert AK; Hofmann P; Liekweg A; Kunze A; Scheid C; Hermes-Moll K; Osburg S; Jaehde U
    Z Evid Fortbild Qual Gesundhwes; 2022 Dec; 175():29-42. PubMed ID: 36372643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential medicine waste in the process of outpatients receiving cost-free medicines from medicine pick-up lockers in the North Denmark region.
    Routhe LG; Andersen IB; Eisenhardt MVG; Mejlholm MB; Wisby HB; Olesen AE
    Eur J Hosp Pharm; 2024 Jun; ():. PubMed ID: 38925908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for the practical stability studies of anticancer drugs: a European consensus conference.
    Bardin C; Astier A; Vulto A; Sewell G; Vigneron J; Trittler R; Daouphars M; Paul M; Trojniak M; Pinguet F;
    Ann Pharm Fr; 2011 Jul; 69(4):221-31. PubMed ID: 21840442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidance on Implementing an Oral Chemotherapy Drug Repository Program in a Medically Integrated Pharmacy Setting.
    Monestime S; Magallon T; Jenkins L; Page R
    JCO Oncol Pract; 2021 Jul; 17(7):e448-e453. PubMed ID: 33900790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Charity Financial Assistance for Novel Oral Anticancer Agents.
    Olszewski AJ; Zullo AR; Nering CR; Huynh JP
    J Oncol Pract; 2018 Apr; 14(4):e221-e228. PubMed ID: 29443649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.